EA036554B1 - Сироп от кашля, содержащий амброксола гидрохлорид - Google Patents

Сироп от кашля, содержащий амброксола гидрохлорид Download PDF

Info

Publication number
EA036554B1
EA036554B1 EA201692367A EA201692367A EA036554B1 EA 036554 B1 EA036554 B1 EA 036554B1 EA 201692367 A EA201692367 A EA 201692367A EA 201692367 A EA201692367 A EA 201692367A EA 036554 B1 EA036554 B1 EA 036554B1
Authority
EA
Eurasian Patent Office
Prior art keywords
cough syrup
amount
cough
present
ambroxol hydrochloride
Prior art date
Application number
EA201692367A
Other languages
English (en)
Russian (ru)
Other versions
EA201692367A1 (ru
Inventor
Бернд Пломанн
Катрин Бушелло
Уве Шойринг
Аннетте Зампони
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA201692367A1 publication Critical patent/EA201692367A1/ru
Publication of EA036554B1 publication Critical patent/EA036554B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA201692367A 2014-05-23 2015-05-19 Сироп от кашля, содержащий амброксола гидрохлорид EA036554B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14169642 2014-05-23
PCT/EP2015/060991 WO2015177147A1 (de) 2014-05-23 2015-05-19 Hustensaft enthaltend ambroxol hydrochlorid

Publications (2)

Publication Number Publication Date
EA201692367A1 EA201692367A1 (ru) 2017-05-31
EA036554B1 true EA036554B1 (ru) 2020-11-23

Family

ID=50771186

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692367A EA036554B1 (ru) 2014-05-23 2015-05-19 Сироп от кашля, содержащий амброксола гидрохлорид

Country Status (13)

Country Link
US (1) US20170189330A1 (ko)
EP (1) EP3145491B1 (ko)
JP (1) JP6554168B2 (ko)
KR (1) KR102447263B1 (ko)
CN (2) CN116459204A (ko)
AU (1) AU2015261940B2 (ko)
CA (1) CA2949882C (ko)
EA (1) EA036554B1 (ko)
ES (1) ES2873078T3 (ko)
MX (1) MX2016015303A (ko)
PH (1) PH12016502284B1 (ko)
PL (1) PL3145491T3 (ko)
WO (1) WO2015177147A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018182546A1 (en) 2017-03-27 2018-10-04 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Stabilized pharmaceutical syrup composition comprising terbutaline sulphate and ambroxol hydrochloride
CN114129514A (zh) * 2021-11-15 2022-03-04 华萃国际生物科技(广东)有限公司 一种混悬滴剂及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101352417A (zh) * 2008-08-29 2009-01-28 扬州市三药制药有限公司 盐酸氨溴索口服溶液及其制备方法
CN102125540A (zh) * 2010-01-18 2011-07-20 沈阳华泰药物研究有限公司 含非盐形式的氨溴索药学上可接受的组合物
CN102258462A (zh) * 2011-07-14 2011-11-30 江西川奇药业有限公司 一种提高盐酸氨溴索稳定性的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1417961A1 (en) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH New pharmaceutical compositions containing a combination of ambroxol or bromhexine and isopropamide iodide
CN1546008A (zh) * 2003-12-02 2004-11-17 沈阳药科大学 盐酸氨溴索液体缓释制剂及其制备方法
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
WO2006030221A1 (en) * 2004-09-15 2006-03-23 Cipla Limited Pharmaceutical composition comprising a betaminetic agent and a mucolytic agent
JP2008013542A (ja) * 2006-06-07 2008-01-24 Daiichi Sankyo Healthcare Co Ltd 去痰又は気道杯細胞過形成抑制のための医薬組成物
JP5364330B2 (ja) * 2007-10-10 2013-12-11 第一三共ヘルスケア株式会社 アゼラスチンとアンブロキソールとを含有する医薬組成物
CN101953821A (zh) * 2009-07-15 2011-01-26 北京利乐生制药科技有限公司 一种以左旋沙丁胺醇与氨溴索为主要活性成分的药物组合物
CN102309442A (zh) * 2010-07-07 2012-01-11 澳美制药厂 盐酸氨溴索口服水性组合物及其制备方法
PT2593094T (pt) * 2010-07-12 2018-03-12 Sanofi Aventis Deutschland Composição aquosa contendo bromexina
CN102716128A (zh) * 2012-07-03 2012-10-10 王学军 一种治疗哮喘的药用组合物
CN102940616A (zh) * 2012-11-21 2013-02-27 北京润德康医药技术有限公司 一种盐酸氨溴索口腔分散膜剂

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101352417A (zh) * 2008-08-29 2009-01-28 扬州市三药制药有限公司 盐酸氨溴索口服溶液及其制备方法
CN102125540A (zh) * 2010-01-18 2011-07-20 沈阳华泰药物研究有限公司 含非盐形式的氨溴索药学上可接受的组合物
CN102258462A (zh) * 2011-07-14 2011-11-30 江西川奇药业有限公司 一种提高盐酸氨溴索稳定性的方法

Also Published As

Publication number Publication date
CA2949882A1 (en) 2015-11-26
MX2016015303A (es) 2017-03-06
US20170189330A1 (en) 2017-07-06
WO2015177147A1 (de) 2015-11-26
PH12016502284A1 (en) 2017-02-13
PH12016502284B1 (en) 2017-02-13
CN116459204A (zh) 2023-07-21
EP3145491A1 (de) 2017-03-29
KR20170010404A (ko) 2017-01-31
CA2949882C (en) 2023-02-28
CN106413688A (zh) 2017-02-15
AU2015261940B2 (en) 2020-07-09
ES2873078T3 (es) 2021-11-03
JP6554168B2 (ja) 2019-07-31
JP2017516849A (ja) 2017-06-22
EA201692367A1 (ru) 2017-05-31
PL3145491T3 (pl) 2021-11-02
KR102447263B1 (ko) 2022-09-26
EP3145491B1 (de) 2021-04-21
AU2015261940A1 (en) 2016-12-08

Similar Documents

Publication Publication Date Title
JP5979763B2 (ja) ブロムヘキシンを含む水性組成物
EA036554B1 (ru) Сироп от кашля, содержащий амброксола гидрохлорид
TW201345563A (zh) 用於經口投藥之包含安布索、左旋羥丙哌嗪及緩衝劑的液體調配物以及製備其之方法
US20220218606A1 (en) Ready to use diclofenac stick packs
JP2002348236A (ja) 医薬液剤
CN112438947B (zh) 羧甲司坦口服溶液及其制备方法
KR102391494B1 (ko) 몬테루카스트 또는 이의 약제학적으로 허용가능한 염을 포함하는 안정성이 개선된 액상 제제 및 이의 제조방법
BR112016027180B1 (pt) Xarope para tosse contendo cloridato de ambroxol
JP5298526B2 (ja) 内服用組成物
EA032834B1 (ru) Стабилизированный десмопрессин
US20160008306A1 (en) Diclofenac sublingual spray
CN115400090A (zh) 一种雷沙吉兰的口崩片组合物及其制备方法

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG TJ TM